Relmada Therapeutics, Inc. (RLMD) Earnings
NASDAQ·Healthcare·Biotechnology
$4.57
+12.16%
Mkt Cap $426.90M
EPS — Estimate vs Actual
Mkt Cap
$426.90M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.11
NASDAQ·Healthcare·Biotechnology
$4.57
+12.16%
Mkt Cap $426.90M
Mkt Cap
$426.90M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.11